The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes
Open accessAbstract
Oligodendrocytes myelinate axons for rapid impulse conduction and contribute to normal axonal functions in the central nervous system. In multiple sclerosis, demyelination is caused by autoimmune attacks, but the role of oligodendroglial cells in disease progression and axon degeneration is unclear. Here we show that oligodendrocytes harbor peroxisomes whose function is essential for maintaining white matter tracts throughout adult life. By selectively inactivating the import factor PEX5 in myelinating glia, we generated mutant mice that developed normally, but within several months showed ataxia, tremor and premature death. Absence of functional peroxisomes from oligodendrocytes caused widespread axonal degeneration and progressive subcortical demyelination, but did not interfere with glial survival. Moreover, it caused a strong proinflammatory milieu and, unexpectedly, the infiltration of B and activated CD8+ T cells into brain lesions. We conclude that peroxisomes provide oligodendrocytes with an essential neuroprotective function against axon degeneration and neuroinflammation, which is relevant for human demyelinating diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNP)-Pex5 mouse brain, VLCFA accumulation is prominent in OLs, notable in astrocytes, and non-existent in neurons [166].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“Brain OLs account for the majority of VLCFA synthesis [166,204] by using their ELOVL1 [205,206,207,208].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“OL peroxisomes are largely responsible for VLCFA synthesis [204] and degradation [166] in the adult brain.”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“This CNP-Pex5 mutant mouse provided a striking phenocopy of human cALD, with disease onset following normal developmental myelination.”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“The brains of these mice showed strong VLCFA accumulation in myelin, severe axonal loss, severely lower plasmalogen levels, and early microglial increase in white matter, followed by demyelination with characteristic regional variability and inflammation with infiltrating perivascular macrophages and B and T cells.”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“Their peroxisome content is abundant [166,253,315], and they express abundant ALDP in normal microglia in human and mouse brains [156].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“Astrocytes in GFAP-Pex5 KO mice have strong VLCFA accumulation, albeit inferior to that seen in the OLs of CNP-Pex5 KO mice [166,264].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“X-ALD pathogenesis seems to be governed by two major mechanisms acting primarily in OLs: VLCFA accumulation, which causes AMN and is cALD permissive, and a secondary peroxisomal pathology, suggested to be a necessary added mechanism of cALD [166].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“Similarly, selective knockout (KO) of Pex5 in oligodendrocytes by using Cnp-Cre drivers had severe consequences for the adult brain [75].”
From Peroxisomes in brain development and function (2016) · cites this paper as [75]
In the citing paper
“This hypothesis is based on the observation that mice lacking functional peroxisomes in oligodendrocytes initially show normal myelination, but develop axonal swelling followed by cerebral demyelination and infiltration of inflammatory T cells [94].”
From X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects (2012) · cites this paper as [94]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION1
Norton, W. T., & Poduslo, S. E. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb07519.x · Cited by 1,413
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,184
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A. (2003) · Nature Genetics · doi:10.1038/ng1095 · Cited by 1,036
Self-citationSilver Staining of Myelin by Means of Physical Development
Gallyas, F. (1979) · Neurological Research · doi:10.1080/01616412.1979.11739553 · Cited by 936
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889
Self-citationPeroxisomes and oxidative stress
Schrader, M., & Fahimi, H. D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.09.006 · Cited by 838
High cholesterol level is essential for myelin membrane growth
Saher, G., Brügger, B., Lappe-Siefke, C., Möbius, W., Tozawa, R.-I., Wehr, M. C., Wieland, F., Ishibashi, S., & Nave, K.-A. (2005) · Nature Neuroscience · doi:10.1038/nn1426 · Cited by 799
Self-citationAxonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences
Bjartmar, C., & Trapp, B. D. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200106000-00003 · Cited by 479
Dodt, G., Braverman, N., Wong, C., Moser, A. B., Moser, H. W., Watkins, P. A., Valle, D. L., & Gould, S. J. (1995) · Nature Genetics · doi:10.1038/ng0295-115 · Cited by 424
Koivusalo, M., Haimi, P., Heikinheimo, L., Kostiainen, R. K., & Somerharju, P. J. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31176-7 · Cited by 417
Simpson, J. E., Newcombe, J., Cuzner, M. L., & Woodroofe, M. N. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00208-7 · Cited by 403
McManus, C. M., Berman, J. W., Brett, F. M., Staunton, H., Farrell, M., & Brosnan, C. F. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00002-2 · Cited by 381
Disease mechanisms in inherited neuropathies
Suter, U., & Scherer, S. S. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1196 · Cited by 351
Edgar, J. M., McLaughlin, M., Yool, D., Zhang, S.-C., Fowler, J. H., Montague, P., Barrie, J. A., McCulloch, M. C., Duncan, I. D., Garbern, J., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312012 · Cited by 328
Self-citationLazzarini, R. A., Griffin, J. W., Lassman, H., Nave, K., Miller, R. H., & Trapp, B. D. (2004) · Elsevier eBooks · doi:10.1016/b978-0-12-439510-7.x5051-7 · Cited by 313
Self-citationFerreirinha, F., Quattrini, A., Pirozzi, M., Valsecchi, V., Dina, G., Broccoli, V., Auricchio, A., Piemonte, F., Tozzi, G., Gaeta, L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420138 · Cited by 308
A mouse model for X-linked adrenoleukodystrophy
Lu, J.-F., Lawler, A. M., Watkins, P. A., Powers, J. M., Moser, A. B., Moser, H. W., & Smith, K. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9366 · Cited by 293
A mouse model for Zellweger syndrome
Baes, M., Gressens, P., Baumgart, E., Carmeliet, P., Casteels, M., Fransen, M., Evrard, P., Fahimi, D., Declercq, P. E., Collen, D., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-49 · Cited by 275
Self-citationRaivich, G., Jones, L. L., Kloss, C. U. A., Werner, A., Neumann, H., & Kreutzberg, G. W. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-15-05804.1998 · Cited by 273
Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy
Loes, D. J., Fatemi, A., Melhem, E. R., Gupte, N., Bezman, L., Moser, H. W., & Raymond, G. V. (2003) · Neurology · doi:10.1212/01.wnl.0000079050.91337.83 · Cited by 268
Rodemer, C., Thai, T.-P., Brügger, B., Kaercher, T., Werner, H. B., Nave, K., Wieland, F., Gorgas, K., & Just, W. W. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg191 · Cited by 234
Self-citationPeroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders
Wanders, R. J. A., & Waterham, H. R. (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00329.x · Cited by 220
Pujol, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.499 · Cited by 214
Notch1 control of oligodendrocyte differentiation in the spinal cord
Genoud, S., Lappe-Siefke, C., Goebbels, S., Radtke, F., Aguet, M., Scherer, S. S., Suter, U., Nave, K.-A., & Mantei, N. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202002 · Cited by 211
Self-citationPeroxisomes, lipid metabolism, and peroxisomal disorders
Wanders, R. J. A. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.08.016 · Cited by 205
Kobayashi, T., Shinnoh, N., Kondo, A., & Yamada, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6340 · Cited by 197
Mammalian peroxisomes and reactive oxygen species
Schrader, M., & Fahimi, H. D. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0673-1 · Cited by 175
Gutcher, I., Urich, E., Wolter, K., Prinz, M., & Becher, B. (2006) · Nature Immunology · doi:10.1038/ni1377 · Cited by 161
Self-citationJung, M., Sommer, I., Schachner, M., & Nave, K. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-24-07920.1996 · Cited by 145
Self-citationMetabolic control of peroxisome abundance
Chang, C., South, S. T., Warren, D., Jones, J. M., Moser, A. B., Moser, H. W., & Gould, S. J. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.10.1579 · Cited by 139
High-resolution 3D MRI of mouse brain reveals small cerebral structures in vivo
Natt, O., Watanabe, T., Boretius, S., Radulović, J., Frahm, J., & Michaelis, T. (2002) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(02)00211-x · Cited by 133
Self-citationIsolation of animal cell mutants deficient in plasmalogen biosynthesis and peroxisome assembly.
Zoeller, R. A., & Raetz, C. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5170 · Cited by 132
The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder
Dubois-Dalcq, M., Feigenbaum, V., & Aubourg, P. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01319-8 · Cited by 121
Peroxisomal-protein import: is it really that complex?
Gould, S. J., & Collins, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm807 · Cited by 114
Ip, C. W., Kroner, A., Bendszus, M., Leder, C., Kobsar, I., Fischer, S., Wiendl, H., Nave, K., & Martini, R. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1921-06.2006 · Cited by 109
Self-citationKemp, S., & Wanders, R. J. A. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.10.001 · Cited by 82
Hirrlinger, J., Resch, A., Gutterer, J. M., & Dringen, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00999.x · Cited by 81
The Role of CD8+ T Cells in Multiple Sclerosis and its Animal Models
Goverman, J. M., Perchellet, A., & Huseby, E. S. (2005) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010053586264 · Cited by 76
Clinical approach to inherited peroxisomal disorders: A series of 27 patients
Baumgartner, M. R., Poll‐The, B. T., Verhoeven‐Duif, N. M., Jakobs, C., Espeel, M., Roels, F., Rabier, D., Levade, T., Rolland, M.-O., Martínez, M., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440505 · Cited by 67
Late onset white matter disease in peroxisome biogenesis disorder
Barth, P. G., Gootjes, J., Bode, H., Vreken, P., Majoie, C. B. L. M., & Wanders, R. J. A. (2001) · Neurology · doi:10.1212/wnl.57.11.1949 · Cited by 48
Loers, G., Aboul‐Enein, F., Bartsch, U., Lassmann, H., & Schachner, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.06.006 · Cited by 42
Wilken, B., Dechent, P., Brockmann, K., Finsterbusch, J., Baumann, M., Ebell, W., Korenke, G. C., Pouwels, P. J. W., Hanefeld, F. A., & Frahm, J. (2003) · Neuropediatrics · doi:10.1055/s-2003-43254 · Cited by 39
Self-citationImmunopathogenesis of adrenoleukodystrophy: Current understanding
Hudspeth, M. P., & Raymond, G. V. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.10.009 · Cited by 34
Generation of Pex5‐loxP mice allowing the conditional elimination of peroxisomes
Baes, M. I., Dewerchin, M. A., Janssen, A., Collen, D., & Carmeliet, P. (2002) · genesis · doi:10.1002/gene.10047 · Cited by 34
Self-citationMoser, H. W., Bergin, A. M. R., & Cornblath, D. R. (1991) · Biochemistry and Cell Biology · doi:10.1139/o91-070 · Cited by 33
Forss-Petter, S. (1997) · doi:10.1002/(sici)1097-4547(19971201)50:5
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Bielschowsky, M. Die Silberimprägnation der Neurofibrillen. J. Psychol. Neurol. 3, 169–183 (1904).
Cited by
Sorted by citations
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523
Self-citationMyelination and support of axonal integrity by glia
Nave, K.-A. (2010) · Nature · doi:10.1038/nature09614 · Cited by 1,062
Self-citationProgressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Myelination of the Nervous System: Mechanisms and Functions
Nave, K.-A., & Werner, H. B. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013101 · Cited by 983
Self-citationOligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933
Metadata
- Authors
- Kassmann, C. M., Lappe-Siefke, C., Baes, M., Brügger, B., Mildner, A., Werner, H. B., Natt, O., Michaelis, T., Prinz, M., Frahm, J., & Nave, K.-A.
- Affiliations
- Max Planck Institute of Experimental Medicine (DE)
- Max Planck Society (DE)
- KU Leuven (BE)
- Heidelberg University (DE)
- University of Göttingen (DE)
- Corresponding author
- Nave, Klaus-Armin
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-07-22
- Volume
- 39
- Issue
- 8
- Pages
- 969-976
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1971817019
- Cited by
- 357
- References
- 49
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 19 · 2023: 20 · 2022: 12 · 2021: 14 · 2020: 16 · 2019: 7 · 2018: 18 · 2017: 15 · 2016: 17 · 2015: 14 · 2014: 20 · 2013: 31 · 2012: 28
- FWCI
- 17.46
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- GRO (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- peroxisomes, oligodendrocytes, PEX5, axonal degeneration, demyelination, neuroinflammation, multiple sclerosis, white matter, myelination, neuroprotection, CD8+ T cells, B cells, demyelinating disease, mouse mutants
- MeSH terms
- Peroxisome-Targeting Signal 1 Receptor, Animals, Axons, Demyelinating Diseases, Humans, Nerve Fibers, Myelinated, Oligodendroglia, T-Lymphocyte Subsets, Receptors, Cytoplasmic and Nuclear, CD8-Positive T-Lymphocytes, Peroxisomes, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
